The clinical outcome of different types of progesterone used for ovarian stimulation in normalovulatory women

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-14005128

Enrollment

Unknown

Registered

2014-08-17

Start date

2014-08-18

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

MPA group:MPA 10mg/d

P group:P 200mg/d

dydrogesterone group:dydrogesterone 20mg/d

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: infertility women, aged 20-40 years, normal mentrual cycle(23-35 days), tubal or male factors, basal FSH<10IU/L, antral follicle counts more than 5.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

Measure	Time frame
number of oocyte retrieval;	—

Secondary

Measure	Time frame
number of fertilized oocytes;number of viable embryos;clinical pregnancy rate;number of mature oocytes;incidence of premature LH surge;	—

Countries

China

Contacts

Public ContactYanping Kuang

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026